Skip to main content


Figure 2 | Clinical Epigenetics

Figure 2

From: The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia

Figure 2

The levels of circulating Treg cells in untreated acute myeloid leukemia (AML) and the effect of all-trans retinoic acid (ATRA), valproic acid and low-dose cytarabine on regulatory T cells (Treg) cell levels. (Left) The levels of circulating Treg cells were determined for a consecutive group of nine AML patients and these levels were compared with a control group matched for age and gender distribution. The mean level is indicated in the figure. (Right) Treg levels were compared for seven patients before and following treatment with valproic acid, ATRA and low-dose cytarabine.

Back to article page